The Company’s BOD resolved to amend the plan to disperse shareholding of Obigen (New Shareholding Dispersal Method)

1.Date of occurrence of the event:2023/05/08 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios: N/A 5.Cause of occurrence: To coordinate with the business needs of Obigen Pharma Inc. (hereinafter referred to as “Obigen”), and in accordance with related laws and regulations for TWSE/TPEx Listed […]

This article is password protected.

To view the content, please enter your password in the field below